1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A mild skeletal phenotype with overlapping features of Miller syndrome and functional characterisation of two new variants of human dihydroorotate dehydrogenase
(
- Contribution to journal › Article
-
Mark
New insights into complex formation by SARS-CoV-2 nsp10 and nsp14
(
- Contribution to journal › Article
-
Mark
Botryococcus braunii autolysate for the production of deuterium-labeled recombinant protein
(
- Contribution to journal › Article
- 2023
-
Mark
Recombinant Protein Production Using the Baculovirus Expression Vector System (BEVS)
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
Mark
Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome
(
- Contribution to journal › Article
- 2020
-
Mark
Preparation of human dihydroorotate dehydrogenase for interaction studies with lipid bilayers
(
- Contribution to journal › Article
- 2015
-
Mark
ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation.
(
- Contribution to journal › Article
-
Mark
ZnT8 autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody positive type 1 diabetes patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility.
(
- Contribution to journal › Article
-
Mark
Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.
(
- Contribution to journal › Article